Concern about RSV is nothing new for neonatal and pediatric nurses. Recent headlines are making the public aware of something we have been teaching (or trying to teach) forever: RSV is dangerous for babies. So, now that we have their attention, what should we be teaching parents and caregivers of infants about RSV?
Updated:
Human Respiratory Syncytial Virus (RSV)2 is the center of a lot of media attention right now. The fuss, we nurses know, is long overdue. So, any other nurses with a sense of "well yes...this is what we have been trying to tell you, forever!"? Well, the hype is on, so let's take advantage and get some accurate information out there while we have their attention!
What is RSV?
Respiratory Syncytial Virus is a single-stranded, negative-strand RNA virus-A1. For a healthy adult or child, it comes with mild cold-like symptoms, including cough, runny nose, headache, and the like. We often think of it as a virus mainly affecting children. Still, it can make a temporary home in any of our respiratory tracks. We may get a swab that tells us COVID-19 does not cause our symptoms, but we may never know that RSV was the culprit.
When RSV is More Than a Cold
The term "cold virus" is typically associated with upper respiratory symptoms. However, RSV can quickly become more serious, involving upper and lower respiratory tracks. We worry primarily about the babies, but also at risk of severe disease are older adults, anyone with immunocompromise, and anyone with heart and lung disease1.
Infants are most at risk of significant RSV disease, especially premature infants with genetic differences (such as Trisomy 21), congenital heart disease, or neuromuscular disorders. These patients are most at risk of needing hospital admission and respiratory support, including mechanical ventilation. The mortality rate overall is low at an estimated 1%. Still, infants with risk factors make up most of that statistic1.
When the RSV virus causes more clinically significant infection, it can lead to:
What to Teach Parents
RSV is common. It may not be possible to prevent RSV illness in infants entirely. RSV is most common in children, with an estimated 90% having been sick with RSV by age two1. Immunity after infection is short-lived, meaning RSV can reinfect anyone at any time. Teaching prevention and recognition of early signs and symptoms and when to seek help is essential. Provide written information for parents to take home after giving birth. Referring parents to a reliable website2 is also helpful (a simple hand-out with a QR code can work well).
RSV prevention
The principles of infection prevention and control are not unique to RSV. Thanks to COVID-19, never has the public been so aware of basic respiratory virus transmission prevention2, 3:
You can't live in a bubble – when parents are sick
Everyone gets sick, including parents of young infants. Arming parents with information on what to do if they have respiratory symptoms may prevent unnecessary panic and, hopefully, undue guilt and self-blame. As we know, nobody is entirely immune. Here are some tips for parents who are experiencing respiratory symptoms:
When to seek medical attention
Parents should see medical attention if:
Call 911 or emergency services if:
RSV Prophylaxis Injection (palivizumab)
Some infants may be eligible for palivizumab injections, a monthly injection that provides passive immunity during the high-risk season. However, palivizumab is costly, and guidelines for who is eligible differ between regions. Risk factors that may qualify an infant for palivizumab include prematurity, chronic lung disease, congenital heart disease, neuromuscular disorders, and genetic differences such as Trisomy 21. Health organizations must have team members identified as responsible for screening infants for eligibility and providing parents of eligible infants with information about this option1, 3, 5.
What About Vaccination?
Parents understandably have questions about vaccination against RSV. RSV vaccinations are in the news lately, but the headlines sometimes need clarification. RSV vaccines are in the research and development stages. No vaccination is currently available for RSV. Focus on prevention at home, prophylaxis for eligible babies, and when to seek medical help. Vaccine education can wait until it is available.
Bottom Line
RSV has long been a concern of anyone caring for patients with immunocompromise, especially those caring for at-risk infants and children. After a brief break from the intensity of "RSV season,” thanks to the social distancing of the 2021-2022 Winter months, RSV has returned. As we knew it would. RSV has become a topic of conversation and media attention as it makes itself known as a virus deserving our attention. While the interest remains high, it seems like there is no better time to hammer home our message, unchanged over decades: prevention of RSV is critical, especially for babies' first Winter.
Parent Resources
Links to reliable web pages specific to RSV:
References
1 Respiratory Syncytial Virus Infection - National Institutes of Health
2 Respiratory Syncytial Virus Infection (RSV) - Centers for Disease Control and Prevention
3 Respiratory syncytial virus infection: Prevention in infants and children - UpToDate
4 Breastfeeding provides passive and likely long-lasting active immunity
5 Medline Plus - Palivizumab Injection
About Heather Cresswell, NP
Heather Cresswell NP has 26 years experience as a BSN, MSN, NP and specializes in Writing, NICU, Women & Children's Health. Freelance health writer and Nurse Practitioner with special interest in infant, child and women's health
Share this post
Share on other sites